{"id":43733,"date":"2017-12-22T00:00:00","date_gmt":"2017-12-21T23:00:00","guid":{"rendered":"https:\/\/techma.bakertilly.es\/nuevos-fondos-en-diciembre-charme-aina-ii-mediterrania-dcn-mondragon\/"},"modified":"2025-03-12T11:42:49","modified_gmt":"2025-03-12T10:42:49","slug":"nuevos-fondos-en-diciembre-charme-aina-ii-mediterrania-dcn-mondragon","status":"publish","type":"post","link":"https:\/\/techma.bakertilly.es\/en\/nuevos-fondos-en-diciembre-charme-aina-ii-mediterrania-dcn-mondragon\/","title":{"rendered":"New funds in December: Charme, Aina II, Mediterrania, DCN, Mondrag\u00f3n"},"content":{"rendered":"<p>Find out about the new venture capital and venture capital funds that have emerged in the month of December and all related information: size, commitments, objective, promoters,...<\/p>\n<p>\nFind out about the new venture capital and venture capital funds that have emerged in the month of December and all related information: size, commitments, objective, promoters,...<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Charme_Capital_Partners_prepara_su_nuevo_fondo_europeo_de_E650M\"><\/span>Charme Capital Partners readies its new \u20ac650M European fund<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The <a href=\"http:\/\/www.charmecapitalpartners.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">Charme Capital Partners<\/a> finalises the final closing of its new venture capital vehicle in Europe, which will arrive by the end of the year with an amount close to \u20ac650M. This amount far exceeds the initial target of \u20ac250m, with commitments of \u20ac400m.<\/p>\n<p>The objective of this new fund is to invest in mid-sized European companies, with Spain, Italy and the UK as priority targets, with a valuation of \u20ac100M to \u20ac500M and strong growth potential. One of the investees of this new investment vehicle is Igenomix, a world leader in the development of genetic fertility tests. Its limited partners include family offices and industrial investors.<\/p>\n<p>&nbsp;<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Aina_Hospitality_y_Edmund_de_Rothschild_lanzan_Aina_II\"><\/span>Aina Hospitality and Edmund de Rothschild launch Aina II<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"http:\/\/ainahospitality.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">Aina Hospitality<\/a>a management company specialising in the hotel sector and promoted by the large asset management group <a href=\"http:\/\/www.edmond-de-rothschild.com\/site\/International\/en\" target=\"_blank\" rel=\"noopener noreferrer\">Edmund de Rothschild<\/a>The company plans to invest \u20ac600m with its second fund, which will target four-star superior and five-star hotels. The two entities have set up a joint venture to promote investment funds in the hotel sector every three years.<\/p>\n<p>Fundraising will start in September and run for a year and a half, with a first closing window in March 2018. It aims to reach \u20ac300M and double its capacity to \u20ac600M with leverage. While in its first fund, Aina I, the minimum entry investment was \u20ac1M, for Aina II there is no set ticket, although it is expected to be higher. The return of Aina II will be close to 12% per annum and will extend its scope to 35 European cities, including countries outside the eurozone such as the UK, Switzerland and Scandinavia.<\/p>\n<p>&nbsp;<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Mediterrania_Capital_Partners_capta_E103M_para_su_tercer_fondo_africano\"><\/span>Mediterrania Capital Partners raises \u20ac103M for third African fund<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The venture capital manager <a href=\"https:\/\/www.mcapitalp.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">Mediterrania Capital Partners (MCP)<\/a> is now ready to launch its third fund specialising in small and medium-sized companies in the Maghreb. Unlike the two previous vehicles, Mediterrania Capital III (MC III) will also invest in Egypt, Senegal, Cameroon and C\u00f4te d'Ivoire, in addition to Morocco, Tunisia and Algeria. The new fund already has \u20ac103m committed, slightly more than the \u20ac100m initially planned. Mediterrania expects to complete this vehicle by December 2018 with \u20ac250M. MC III will carry out eight to twelve transactions of \u20ac10M to \u20ac30M, in key sectors in North Africa and Sub-Saharan Africa, such as healthcare, consumer goods, finance, education, transport and logistics.<\/p>\n<h2><\/h2>\n<h2><span class=\"ez-toc-section\" id=\"DCN_registra_ante_la_CNMV_su_fondo_de_biomedicina_Dosbio50\"><\/span>DCN registers its biomedicine fund Dosbio50 with the CNMV<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Valencian firm <a href=\"http:\/\/www.dcn.es\/\" target=\"_blank\" rel=\"noopener noreferrer\">Decenes Mecenes (DCN)<\/a> ha registrado ante la CNMV el fondo de capital riesgo\u00a0Dosbio50 Life Science &amp; Health Care Venture Capital Investments, que prev\u00e9 gestionar m\u00e1s de \u20ac40M para invertir en proyectos de capital semilla y\/o capital deesarrollo del sector de la biomedicina.\u00a0Dosbio50 ser\u00e1 gestionado por su administrador \u00fanico, la gestora de DCN, que recibi\u00f3 en abril la pertinente autorizaci\u00f3n de la CNMV y est\u00e1 presidida por Lucas Mart\u00ednez Clar y participada en un 5,49% por la sociedad de inversi\u00f3n valenciana Realiza Business Angels.<\/p>\n<p>Throughout its ten years of existence, Realiza Business Angels has made a total of 17 investments in the Life Science sector (health sciences) with Artax Biopharma, Imegen, BioncoTech, Universal Diagnostics and the aforementioned Dosbio50; digital technology with Jugo, 50Tresdigital, Encom, Beroomers, Nextail and Weplan; as well as Soluble Film Packaking and Consultia Travel. It has also divested SFP, Corporate Channels, Geothermal Energy and Photomiracle.<\/p>\n<p>&nbsp;<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Clave_Mayor_y_Corporacion_Mondragon_lanzan_un_fondo_de_E15M_para_spin-outs\"><\/span>Clave Mayor and Corporaci\u00f3n Mondrag\u00f3n launch \u20ac15M fund for spin-outs<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>La <a href=\"https:\/\/www.mondragon-corporation.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">Mondragon Corporation<\/a> ha lanzado \u00abMondrag\u00f3n Fondo de Promoci\u00f3n F.C.R.\u00bb, ya inscrito en la CNMV, operativo y gestionado por la firma de capital riesgo <a href=\"http:\/\/www.clavemayor.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">Major Key<\/a>. Se trata de un nuevo veh\u00edculo de inversi\u00f3n de &#8216;spin-outs&#8217; que tiene como objetivo apoyar la transferencia tecnol\u00f3gica de proyectos de base tecnol\u00f3gica e innovadora del sector industrial, salud y energ\u00eda que provengan principalmente de la propia Corporaci\u00f3n.<\/p>\n<p>The fund, closed with commitments of \u20ac15 million, also has the participation of FOND-ICO Global FCR, and the venture capital companies of the Basque and Navarre Governments, as well as the Provincial Council of Gipuzkoa. The investment vehicle will invest over the next 6 years in 30 companies with less than two years of life, remaining between 4 and 5 years in each of the investees and allocating up to \u20ac500,000 to each of them.<\/p>\n<p>&nbsp;<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Nace_Genesis_Ventures_nuevo_fondo_de_inversion_en_biomedicina\"><\/span>Genesis Ventures, a new biomedical investment fund, is born<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Genesis Ventures, un nuevo fondo de inversi\u00f3n ubicado en Barcelona e integrado por varias family offices, apostar\u00e1 por proyectos de investigaci\u00f3n y empresariales en fase muy temprana del \u00e1mbito de la biomedicina: terap\u00e9utica, diagn\u00f3stico, dispositivos m\u00e9dicos, salud digital, entre otros. Su objetivo es ayudar a los emprendedores a alcanzar el valor necesario de su investigaci\u00f3n para, posteriormente, atraer la primera ronda de inversi\u00f3n de fondos corporativos o capital riesgo (Series A). El nuevo fondo tendr\u00e1 un tama\u00f1o cercano a los \u20ac610.000 y espera realizar un total de ocho operaciones hasta octubre de 2019.<\/p>\n<h2><\/h2>\n<h2><span class=\"ez-toc-section\" id=\"Eneko_Knorr_lanza_Pheidon_especializado_en_bitcoins\"><\/span>Eneko Kn\u00f6rr launches Pheidon, specialising in bitcoins<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Eneko Kn\u00f6rr, apoyado por un equipo de expertos en blockchain y criptomonedas procedentes de Silicon Valley, Singapur y Espa\u00f1a, ha lanzado Pheidon, un fondo que empezar\u00e1 a operar en 2018 y est\u00e1 todav\u00eda pendiente de recibir la aprobaci\u00f3n de la CNMV. El fondo pretende facilitar la inversi\u00f3n en Bitcoin ya que, seg\u00fan Kn\u00f6rr, \u00abhace tiempo que veo en Espa\u00f1a un gran inter\u00e9s en invertir en Bitcoin, pero no es f\u00e1cil: los peque\u00f1os ahorradores encuentran el proceso muy complicado, y las grandes fortunas no tienen ning\u00fan fondo desde el que invertir\u00bb.<\/p>","protected":false},"excerpt":{"rendered":"<p>Find out about the new venture capital and venture capital funds that have emerged in the month of December and all related information: size, commitments, objective, promoters,...<\/p>","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[1750],"tags":[312,155,153,1205,624],"sectores":[],"tipo-contenido":[2260],"class_list":["post-43733","post","type-post","status-publish","format-standard","hentry","category-financiacion-sectorial","tag-capital-riesgo-espana","tag-corporate-finance-spain","tag-global-corporate-finance","tag-nuevos-fondos-espana","tag-venture-capital-espana","tipo-contenido-noticias"],"acf":[],"_links":{"self":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/posts\/43733","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/comments?post=43733"}],"version-history":[{"count":0,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/posts\/43733\/revisions"}],"wp:attachment":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/media?parent=43733"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/categories?post=43733"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/tags?post=43733"},{"taxonomy":"sectores","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/sectores?post=43733"},{"taxonomy":"tipo-contenido","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/tipo-contenido?post=43733"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}